JUNG GUNDRAM has a total of 18 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and biotechnology are VASCULOX INC, BIO TECHNOLOGY GENERAL ISRAEL and PEPHARM R & D LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Germany | 2 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Jung Gundram | 17 |
#2 | Grosse-Hovest Ludger | 5 |
#3 | Grosse Hovest Ludger | 1 |
Publication | Filing date | Title |
---|---|---|
EP2780372A1 | Bi-specific antibodies for medical use | |
DE10156482A1 | Bispecific antibody molecule | |
DE10034607A1 | Multi-specific reagent for the selective stimulation of cell surface receptors |